Bruker (BRKR) Sets a New 52-Week High at $64.51

As seen on the 24/7 Wall St. homepage on September 29, 2026.

BRKR Bruker

6:00pm ET

New 52-week high $64.51 +0.3% vs prior high · 2026-07-30

Bruker closed at $64.51, a fresh 52-week high that edges 0.26% past the July 30 peak and nearly doubles its March low near $32.71. The $9.8 billion name now has a clean new level for traders to defend.

Continue ReadingShow less

Bruker closed at $64.51 on September 29, clearing its previous 52-week peak and leaving no overhead resistance from the past year. The stock is now trading on entirely fresh ground.

Bruker touched a low near $32.71 earlier in the year, so the stock has essentially doubled off that trough. Recoveries like that draw momentum investors who screen for names making new highs.

The period split into a grind lower toward the low $30s and a nearly uninterrupted climb back through prior resistance. The most recent leg set a fresh benchmark.

The immediate question is whether $64.51 becomes a floor or a false breakout. New 52-week highs that hold tend to attract additional buying, since no sellers are anchored at higher prices. Keep an eye on volume in the next few sessions.

Sources

BRKR company overview

Mentioned: BRKR, BRKRP, BRUKP

Related Market Updates

Biggest movers · At the close Sep 24, 4:11pm ET

Gainers

BRKRBruker$64.13+7.5%
TEMTempus AI$82.15+7.3%
IONQIonQ$45.01+5.8%
AFRMAffirm$71.54+5.1%
METAMeta$778.35+4.6%

Losers

ARMArm$304.35-8.5%
APPSDigital Turbine$10.94-5.2%
GPROGoPro$1.25-4.6%
GMGeneral Motors$80.22-4.2%
SNDKSanDisk$1,753.24-3.5%

Arm's 8.5% slide was the deepest move in a 111-stock priority list at Wednesday's close, with Bruker leading the upside at 7.5%.

BRKR Bruker

Regular session

Sep 24, 3:40pm ET

$64.88

+9.64% open $59.17

A 9.6% intraday jump adds close to a billion dollars of market value to a $9.9 billion company in a single session. Moves this size are rare for a life sciences tools name, so watch whether the gain holds into the close.

BRKR Bruker

Sep 21, 6:00pm ET

Dividend $0.05 ex-date 2026-09-21 · 0.41% yield · 10 yrs paying

Bruker holds its nickel quarterly payout for a 10th straight year, unchanged from a year ago. At 0.41%, the yield is a token of consistency rather than income, so the instruments business is the reason to own it.

Biggest movers · At the close Sep 16, 4:10pm ET

Gainers

CIFRCipher Mining$16.66+10.4%
BRKRBruker$60.87+9.2%
IQiQIYI$1.08+8.0%
COHRCoherent$290.33+7.1%
AXONAxon Enterprise$471.39+6.6%

Losers

ONON Semiconductor$66.66-8.9%
FANGDiamondback Energy$195.04-7.8%
APPSDigital Turbine$10.78-5.3%
ACHRArcher Aviation$5.22-4.6%
DUOLDuolingo$148.19-3.7%

Cipher Mining closed the session up 10.4% at $16.66, the widest gain across 111 priority names. At the other end, ON Semiconductor gave up 8.9% and Diamondback Energy 7.8%, a roughly 19-point spread between the best and worst names on the day.

Biggest movers · At the close Sep 15, 4:10pm ET

Gainers

TEMTempus AI$68.74+10.5%
BRKRBruker$55.97+6.3%
QCOMQualcomm$187.79+4.2%
SSentinelOne$23.47+3.8%
RBRKRubrik$103.47+3.3%

Losers

AXONAxon Enterprise$444.7-9.3%
CAVACava$49.8-9.3%
CLOVClover Health$4.64-9.1%
FUBOfuboTV$10.9-8.2%
OPENOpendoor Technologies$2.65-5.2%

Tempus AI closed the session up 10.5%, the only double-digit move among 111 tracked names. The downside was deeper and broader: Axon, Cava and Clover Health all gave up more than 9%.

Biggest movers · At the close Aug 4, 4:10pm ET

Gainers

PLTRPalantir$162.55+29.4%
AAOIApplied Optoelectronics$132.64+20.4%
ARMArm$280.61+17.4%
FNFabrinet$534.46+17.2%
COHRCoherent$330.85+14.8%

Losers

BRKRBruker$51.17-20.4%
VERXVertex$11.74-12.4%
CIFRCipher Mining$21.25-12.1%
AMCAMC Entertainment$2.63-7.7%
NVONovo Nordisk$44.09-6.4%

Palantir's 29% close pulled the entire AI complex with it, from Arm to the optical names supplying the data centers. Everything outside that trade got sold, with Bruker down 20% and Novo Nordisk sliding again.

BRKR Bruker

Q2 2026

Aug 4, 7:00am ET

EPS

$0.49

est $0.38 +27.5%

Revenue

$839M

est $854M -1.8%

Non-GAAP operating margin jumped to 14.1% from 9.0% a year ago, turning a slight revenue miss into an earnings beat. Scientific Instruments bookings rose organically on semiconductor tools, energy research and biopharma demand, with US academic orders still the weak link. Full-year EPS guidance stands, and management is now pointing to more margin expansion in 2027.

BRKR Bruker Corporation

Reports Tue Aug 4 Before open 6:30 AM ET Confirmed

Aug 4, 5:00am ET

Bruker reports Q2 before the bell at 6:30 AM ET, and it lands before Thermo Fisher and Agilent investors get their own read on whether biopharma R&D budgets are opening back up. Instrument order trends here set the tone for the whole life science tools group.